Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

CVS Health

Pfizer

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields

PDCO's latest agreement with PDS Health to extend their deal is likely to streamline operations, optimize efficiency and maximize profitability.

Patterson Companies Stock Up Following Latest Partnership Extension

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced an agreement in principle between Patterson and PDS Health, a leading dental and medical support organization formerly known as Pacific Dental Services, to extend their strategic relationship through the end of 2027. The extension allows Patterson to continue as the premier distributor for all merchandise, services, technology and core equipment across PDS H.

Patterson Dental Extends Strategic Relationship With PDS Health

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies Inc. (Nasdaq: PDCO) announced the appointment of Kristin Dietzler as Patterson Dental's North American president. Dietzler brings extensive expertise in adjacent healthcare companies with a proven track record of success in optimizing results. She will report to Kevin Pohlman, chief operating officer of Patterson Companies, and she will be a member of the company's executive leadership team. Dietzler joins Patterson Dental with nearly 30 yea.

Patterson Companies Announces Dental Leadership Appointment

Investors remain optimistic about Patterson Companies on the back of its broad product line.

Here's Why You Should Retain PDCO Stock in Your Portfolio for Now

Patterson Companies announces to invest in two separate businesses to boost its animal health business.

PDCO Shares Gain Following New Deals to Boost Animal Health Business

Patterson Cos. (PDCO) reported earnings 30 days ago.

Why Is Patterson Cos. (PDCO) Down 4.2% Since Last Earnings Report?

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) a leading distribution company in the dental and animal health industries, today announced that it has signed two separate acquisition agreements for its Animal Health business – Infusion Concepts in the United Kingdom and Mountain Vet Supply in the United States. Patterson's U.K. animal health business, National Veterinary Services Limited (NVS), is set to acquire Infusion Concepts Ltd., a market leader in the design an.

Patterson Invests in Business in the U.S. and U.K.

SAINT PAUL, Minn.--(BUSINESS WIRE)--On September 17, 2024, the Board of Directors of Patterson Companies, Inc. (Nasdaq: PDCO) declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on, or about, November 1, 2024, to shareholders of record as of the close of business on October 18, 2024. About Patterson Companies Inc. Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies,.

Patterson Companies Declares Regular Quarterly Cash Dividend

AMN Healthcare Services

Scilex Holding Co

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 3 Health Care Stocks That Could Blast Off In September

Patterson Companies announced disappointing fiscal 2025 Q1 results. A cyberattack on Change Healthcare affected Patterson more than expected.

Why Patterson Companies Stock Is Plunging Today

Patterson Companies, Inc. (NASDAQ:PDCO ) Q1 2025 Earnings Conference Call August 28, 2024 8:30 AM ET Company Participants John Wright - Vice President, Investor Relations Don Zurbay - President and Chief Executive Officer Kevin Barry - Chief Financial Officer Conference Call Participants Jonathan Block - Stifel Brandon Vazquez - William Blair Allen Lutz - Bank of America Jeffrey Johnson - Robert W. Baird Elizabeth Anderson - Evercore ISI Jason Bednar - Piper Sandler Michael Cherny - Leerink Partners Erin Wright - Morgan Stanley Operator Good morning and welcome to the Patterson Companies, Inc. First Quarter Fiscal 2025 Earnings Call.

Patterson Companies, Inc. (PDCO) Q1 2025 Earnings Call Transcript

Patterson Companies' first-quarter fiscal 2025 results reflect the negative impact of a cyberattack on its vendor, Change Healthcare.

PDCO Stock Falls on Q1 Earnings & Sales Miss, Gross Margin Up Y/Y

Although the revenue and EPS for Patterson Cos. (PDCO) give a sense of how its business performed in the quarter ended July 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Patterson Cos. (PDCO) Reports Q1 Earnings: What Key Metrics Have to Say

Patterson Cos. (PDCO) came out with quarterly earnings of $0.24 per share, missing the Zacks Consensus Estimate of $0.32 per share.

Patterson Cos. (PDCO) Lags Q1 Earnings and Revenue Estimates

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported operating results for its fiscal 2025 first quarter ended July 27, 2024. "Our first quarter results fell short of our expectations, primarily due to the greater than anticipated impact of the Change Healthcare cybersecurity attack on the value-added services category in our dental segment, along with lower sales in our companion animal business and the timing of certain corporate expenses," said Don Zurbay.

Patterson Companies Reports Fiscal 2025 First Quarter Operating Results

Patterson Dental Fuse and Eaglesoft practice management software users can increase their clinical efficiency with Bola AI's Voice-AI technology ORANGE COUNTY, Calif. , Aug. 26, 2024 /PRNewswire/ -- Bola Technologies, Inc. (Bola AI), the leading provider of Voice-AI technology for dental professionals has announced a new software integration with Patterson Dental Supply, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO) within their Fuse practice management software and Eaglesoft practice management software.

PATTERSON DENTAL AND BOLA AI BRING INTEGRATED VOICE AI TO PRACTICES

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect an improvement in both the Dental and Animal Health segments on the back of comprehensive product offerings.

Broad Portfolio to Aid Patterson Companies' (PDCO) Q1 Earnings

Besides Wall Street's top -and-bottom-line estimates for Patterson Cos. (PDCO), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended July 2024.

Stay Ahead of the Game With Patterson Cos. (PDCO) Q1 Earnings: Wall Street's Insights on Key Metrics

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2025 first-quarter conference call on Wednesday, August 28, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The fiscal 2025 first-quarter earnings conference call replay will be available begi.

Patterson Companies Fiscal 2025 First Quarter Conference Call Scheduled for Wednesday, August 28, 2024

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, the trusted partner for the dental and animal health markets, announced the release of its fiscal year 2024 Corporate Responsibility Report. The report focuses on our effort as an organization to promote an inclusive workplace, reduce the company's carbon footprint, and execute a DE&I strategy. These initiatives allow us to hold ourselves accountable and align back to the company values. “I'm proud of our company as we continue to chall.

Patterson Companies Releases 2024 Corporate Responsibility Report

Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.

Reasons to Hold Patterson Companies (PDCO) in Your Portfolio Now

Patterson Companies ( PDCO ) subsidiary Patterson Dental Canada recently collaborated with Pearl to expand access to its Second Opinion AI disease detection capabilities in Canada's dental market. Pearl's real-time pathology detection AI software assists dentists in accurately evaluating dental conditions in X-rays, such as caries, bone loss and calculus.

Patterson (PDCO) Expands AI Solutions in Canada via Alliance

LOS ANGELES--(BUSINESS WIRE)--Pearl, the global leader in dental AI solutions, and Patterson Dental Canada, Inc., a subsidiary of Patterson Companies, Inc. (Nasdaq: PDCO), today announced a collaboration to expand access to Pearl's Second Opinion® AI disease detection capabilities within the Canadian dental market. Pearl's real-time pathology detection AI software, Second Opinion®, assists dentists in their radiologic evaluation and case presentation of dental conditions commonly found in denta.

Pearl and Patterson Dental Canada Join Forces to Advance Dental AI in Canadian Dentistry

BOULDER, Colo.--(BUSINESS WIRE)--Radia will partner with aerospace leaders Aernnova, Leonardo, AFuzion to build WindRunner, the world's largest aircraft that will expand wind energy.

News for Patterson Companies Stock (PDCO)